Chemotherapy Induced Nausea and Vomiting:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Chemotherapy Induced Nausea and Vomiting 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 21
Clinical Trials in E7 Nations by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Unaccomplished Trials of Chemotherapy Induced Nausea and Vomiting 26
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Chemotherapy Induced Nausea and Vomiting Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Merck & Co., Inc. 36
Clinical Trial Overview of Merck & Co., Inc. 36
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Helsinn Healthcare S.A. 40
Clinical Trial Overview of Helsinn Healthcare S.A. 40
ProStrakan Group plc 42
Clinical Trial Overview of ProStrakan Group plc 42
Tesaro, Inc. 43
Clinical Trial Overview of Tesaro, Inc. 43
Acacia Pharma Ltd. 44
Clinical Trial Overview of Acacia Pharma Ltd. 44
Mylan Pharmaceuticals Inc. 45
Clinical Trial Overview of Mylan Pharmaceuticals Inc. 45
A.P. Pharma, Inc. 46
Clinical Trial Overview of A.P. Pharma, Inc. 46
Par Pharmaceutical Companies, Inc. 47
Clinical Trial Overview of Par Pharmaceutical Companies, Inc. 47
Ono Pharmaceutical Co., Ltd. 48
Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 48
Insys Therapeutics, Inc. 49
Clinical Trial Overview of Insys Therapeutics, Inc. 49
RedHill Biopharma Ltd. 50
Clinical Trial Overview of RedHill Biopharma Ltd. 50
Dr. Reddy’s Laboratories Limited 51
Clinical Trial Overview of Dr. Reddy’s Laboratories Limited 51
Solasia Pharma K.K. 52
Clinical Trial Overview of Solasia Pharma K.K. 52
LG Life Sciences, Ltd. 53
Clinical Trial Overview of LG Life Sciences, Ltd. 53
IPCA Laboratories Limited 54
Clinical Trial Overview of IPCA Laboratories Limited 54
Eisai Inc. 55
Clinical Trial Overview of Eisai Inc. 55
Halozyme Therapeutics, Inc. 56
Clinical Trial Overview of Halozyme Therapeutics, Inc. 56
Schering-Plough Corporation (Inactive) 57
Clinical Trial Overview of Schering-Plough Corporation (Inactive) 57
Teva Pharmaceutical Industries Limited 58
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 58
Clinical Trial Overview of Top Institutes / Government 59
The University of Texas M. D. Anderson Cancer Center 59
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 59
University of Rochester 60
Clinical Trial Overview of University of Rochester 60
Memorial Sloan Kettering Cancer Center 61
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 61
Kitasato University School of Medicine 62
Clinical Trial Overview of Kitasato University School of Medicine 62
Duke University 63
Clinical Trial Overview of Duke University 63
OHSU Knight Cancer Institute 64
Clinical Trial Overview of OHSU Knight Cancer Institute 64
Yokohama City University 65
Clinical Trial Overview of Yokohama City University 65
Tokushima University Hospital 66
Clinical Trial Overview of Tokushima University Hospital 66
Washington University School of Medicine 67
Clinical Trial Overview of Washington University School of Medicine 67
National Cancer Institute 68
Clinical Trial Overview of National Cancer Institute 68
University of Oklahoma 69
Clinical Trial Overview of University of Oklahoma 69
Kyoto University 70
Clinical Trial Overview of Kyoto University 70
University of Washington 71
Clinical Trial Overview of University of Washington 71
All India Institute of Medical Sciences 72
Clinical Trial Overview of All India Institute of Medical Sciences 72
The Hospital for Sick Children 73
Clinical Trial Overview of The Hospital for Sick Children 73
Thomas Jefferson University 74
Clinical Trial Overview of Thomas Jefferson University 74
Gynecologic Oncology Group 75
Clinical Trial Overview of Gynecologic Oncology Group 75
Kobe University 76
Clinical Trial Overview of Kobe University 76
The University of Manchester 77
Clinical Trial Overview of The University of Manchester 77
Shizuoka Cancer Center 78
Clinical Trial Overview of Shizuoka Cancer Center 78
Five Key Clinical Profiles 79
Appendix 153
Abbreviations 153
Definitions 153
Research Methodology 154
Secondary Research 154
About GlobalData 155
Contact Us 155
Disclaimer 155
Source 156


【レポート販売概要】

■ タイトル:Chemotherapy Induced Nausea and Vomiting:グローバル臨床試験レビューH2, 2013
■ 英文:Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013
■ 発行日:2013年9月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162123
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。